{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Disease&page=26", "query": { "condition": "Adult Disease", "page": 26 }, "page_size": 10 }, "pagination": { "page": 26, "page_size": 10, "total_count": 13266, "total_pages": 1327, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Disease&page=27&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Disease&page=25&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T19:06:50.074Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04881825", "title": "Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Short Bowel Syndrome" ], "interventions": [ { "name": "Glepaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zealand Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 84, "start_date": "2021-06-16", "completion_date": "2026-04-30", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 4, "location_summary": "Washington D.C., District of Columbia • Rochester, Minnesota • Omaha, Nebraska + 1 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04881825" }, { "nct_id": "NCT00563368", "title": "A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "VI-0521", "type": "DRUG" }, { "name": "topiramate", "type": "DRUG" }, { "name": "phentermine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VIVUS LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 756, "start_date": "2007-12", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2015-03-30", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 2, "location_summary": "Durham, North Carolina • Philadelphia, Pennsylvania", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00563368" }, { "nct_id": "NCT05219968", "title": "Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Sinusitis", "Chronic Rhinosinusitis (Diagnosis)" ], "interventions": [ { "name": "LYR-210", "type": "DRUG" }, { "name": "Sham procedure control", "type": "DRUG" }, { "name": "Background Therapy", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Lyra Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 196, "start_date": "2022-01-27", "completion_date": "2024-09-16", "has_results": true, "last_update_posted_date": "2025-05-02", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Escondido, California • La Mesa, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05219968" }, { "nct_id": "NCT05823974", "title": "A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "F2C22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22A/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22B/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22D/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22E/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22A/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22B/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22D/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22E/DL001Z", "type": "BIOLOGICAL" }, { "name": "Control 1", "type": "COMBINATION_PRODUCT" }, { "name": "F2F23D/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2F23A/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2F23B/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "Control 2", "type": "COMBINATION_PRODUCT" }, { "name": "F2F23C/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "Control 3", "type": "COMBINATION_PRODUCT" }, { "name": "F2F22F/DL001Z", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 1275, "start_date": "2023-04-27", "completion_date": "2024-12-18", "has_results": true, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 24, "location_summary": "Hialeah, Florida • Miami, Florida • Chicago, Illinois + 21 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Valparaiso", "state": "Indiana" }, { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05823974" }, { "nct_id": "NCT02393625", "title": "Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "ALK-positive NSCLC" ], "interventions": [ { "name": "Ceritinib (LDK378)", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 57, "start_date": "2015-05-27", "completion_date": "2027-04-09", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 4, "location_summary": "Scottsdale, Arizona • Boston, Massachusetts • Philadelphia, Pennsylvania", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02393625" }, { "nct_id": "NCT07168902", "title": "Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "BL1107 Low dose", "type": "DRUG" }, { "name": "BL1107 High dose", "type": "DRUG" }, { "name": "Timolol maleate 0.5%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 252, "start_date": "2025-10-24", "completion_date": "2026-05-18", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 14, "location_summary": "Glendale, California • Newport Beach, California • Pasadena, California + 11 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07168902" }, { "nct_id": "NCT07453537", "title": "Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress Response", "Mental Stress", "Multitasking Behavior and Multitasking Ability", "Physiological Stress", "Cognitive Symptoms", "Motor Activity" ], "interventions": [ { "name": "Cranberry juice", "type": "OTHER" }, { "name": "Placebo juice", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "30 Years to 55 Years" }, "enrollment_count": 84, "start_date": "2026-08-01", "completion_date": "2029-08-01", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07453537" }, { "nct_id": "NCT06625775", "title": "Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor, Adult", "Metastatic Breast Cancer", "Advanced Breast Cancer", "HER2 Mutation-Related Tumors", "HER2-positive Metastatic Breast Cancer", "KRAS Mutant Metastatic Colorectal Cancer", "Metastatic Lung Cancer", "Metastatic Colorectal Cancer", "Advanced Lung Cancer", "HR-positive, HER2-negative Advanced Breast Cancer", "HER2-positive Advanced Breast Cancer" ], "interventions": [ { "name": "BBO-10203", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "FOLFOX", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 392, "start_date": "2024-10-29", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 19, "location_summary": "Duarte, California • Los Angeles, California • San Diego, California + 13 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06625775" }, { "nct_id": "NCT06033001", "title": "Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)", "overall_status": "TEMPORARILY_NOT_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Castration-Resistant Prostatic Cancer" ], "interventions": [ { "name": "[Lu-177]-PNT2002", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lantheus Medical Imaging", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2025-01-13", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 7, "location_summary": "Newport Beach, California • Hartford, Connecticut • Jupiter, Florida + 4 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Jupiter", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Trinity", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06033001" }, { "nct_id": "NCT00723801", "title": "Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Marfan Syndrome" ], "interventions": [ { "name": "Atenolol", "type": "DRUG" }, { "name": "Losartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 40, "start_date": "2007-10", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-09-09", "last_synced_at": "2026-11-15T19:06:50.074Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00723801" } ] }